Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04881942 · ClinicalTrials.gov registry record · NA
Characterization of Selected Aerosol Constituents Levels in the Exhaled Breath of Adult e-Vapor Users
A NA study, sponsored by Altria Client Services.
- Completed
- Registry status
- NA
- Development phase
- 35
- Enrollment target
NCT04881942 is a NA study that has completed, run by Altria Client Services. The registered enrollment target is 35 participants.
The verdict
NCT04881942, a NA study, has completed, sponsored by Altria Client Services.
- COMPLETED
- Registry status
- NA
- Development phase
- 35 participants
- Enrollment target
Study Summary
This is an open-label, 4-way crossover study designed to estimate the nicotine, glycerin, propylene glycol, menthol, formaldehyde, acetaldehyde, and acrolein levels in exhaled breath samples during use of four MarkTen® XL e-vapor products. The study will enroll approximately 32 adult e-vapor-using subjects at one site in the United States in High Point, NC.
Interventions
- OTHER e-Vapor Product A
- OTHER e-Vapor Product B
- OTHER e-Vapor Product C
- OTHER e-Vapor Product D
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 35 participants |
| Start Date | 2017-03-27 |
| Est. Completion | 2018-01-26 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04881942
The ClinicalTrials.gov registry entry for NCT04881942 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 35 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Altria Client Services, which has 10 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which e-Vapor Product A is the first listed.
NCT04881942 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04881942 about?
NCT04881942 is a clinical study titled "Characterization of Selected Aerosol Constituents Levels in the Exhaled Breath of Adult e-Vapor Users". This is an open-label, 4-way crossover study designed to estimate the nicotine, glycerin, propylene glycol, menthol, formaldehyde, acetaldehyde, and acrolein levels in exhaled breath samples during use of four MarkTen® XL e-vapor products. The study will enroll approximately 32 adult e-vapor-using s...
What is the current status of trial NCT04881942?
This trial is currently completed. It is a NA study. The enrollment target is 35 participants. The study started on 2017-03-27. Estimated completion is 2018-01-26.
What interventions are being tested in trial NCT04881942?
The interventions under investigation include: e-Vapor Product A (OTHER), e-Vapor Product B (OTHER), e-Vapor Product C (OTHER), e-Vapor Product D (OTHER).
Who is sponsoring clinical trial NCT04881942?
This trial is sponsored by Altria Client Services, which has 10 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.